A preference trial with rizatriptan 10 mg and ibuprofen 400 mg in migraine patients in the general practice
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 26 Jun 2011
At a glance
- Drugs Ibuprofen; Rizatriptan
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 26 Jun 2011 Results presented at the 15th Congress of the International Headache Society.
- 14 Sep 2009 Planned end date 9 Nov 2006 added as reported by Netherlands Trial Register record.
- 10 Sep 2009 Planned number of patients (35) added, additional trial sponsor Reckitt benckiser added as reported by Netherlands Trial Register record.